Valbenazine Tosylate

N/A

Report date: 2026/05/05 20:00:16
NME

Base Information

Drug NameValbenazine Tosylate
Drug Alias Namevalbenazinum缬苯那嗪valbenazinaValbenazine DitosylateVMAT2 inhibtor(Neurocrine-Biosciences) +[10] 
ClassificationSmall molecules > Amino acid supplement, Lipids and VitaminsSmall molecules > Heterocyclic drugs
Mechanisms of ActionSynaptic vesicular amine transporter inhibitors
TargetsSynaptic vesicular amine transporter
Therapy Area/IndicationsSchizophreniaTrichotillomaniaObsessive-Compulsive Disorder +[9] 
Global Approved IndicationsTardive Dyskinesia
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved Date2017/04/11
Country/TerritoryBelgiumBulgariaCanada +[15] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesNeurocrine Biosciences Inc
China Registration ClassN/A

Develop Information

Active CompaniesYale UniversityMitsubishi Tanabe Pharma CorpThe University Of Chicago +[5] 
Inactive CompaniesN/A
Active IndicationsSchizophreniaTrichotillomaniaObsessive-Compulsive Disorder +[8] 
Inactive IndicationsTourette Syndrome

Other Information

ATC CodeN07XX13
Related LinksWikipediaDrugBankKEGG